Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
37.59
+0.28 (0.75%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Ultragenyx Pharmaceutical Employees
Ultragenyx Pharmaceutical had 1,294 employees as of December 31, 2024. The number of employees increased by 18 or 1.41% compared to the previous year.
Employees
1,294
Change (1Y)
18
Growth (1Y)
1.41%
Revenue / Employee
$432,944
Profits / Employee
-$439,863
Market Cap
3.53B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
RARE News
- 2 days ago - Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 8 days ago - Ultragenyx: Commercial Engine Fuels Rare Disease Pipeline - Seeking Alpha
- 2 months ago - Ultragenyx to Participate at Investor Conferences in March - GlobeNewsWire
- 2 months ago - Ultragenyx Pharmaceutical Inc. (RARE) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Ultragenyx Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Update - GlobeNewsWire
- 2 months ago - Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update - GlobeNewsWire
- 2 months ago - Ultragenyx Announces New Data Demonstrating that Treatment with UX111 AAV Gene Therapy Significantly Improved Clinical Function Across Multiple Developmental Domains in Children with Sanfilippo Syndrome Type A (MPS IIIA) Correlated with Sustained Reductions in CSF-HS - GlobeNewsWire
- 3 months ago - Ultragenyx's Multiple Commercial Assets And Candidates Impress Analyst; Sees Solid Upside - Benzinga